INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›general›GPs can now prescribe ADHD medication – but big barriers to treatment remain
generalBREAKING

GPs can now prescribe ADHD medication – but big barriers to treatment remain

By Info60 Australia Desk•Summary of reporting by theconversation.com•5h ago•0 views•
GPs can now prescribe ADHD medication – but big barriers to treatment remain
In February, NZ rolled out new rules promising easier access to ADHD treatment. Today, gaps in training, cost and access show why the reform was only a first st...
In February, NZ rolled out new rules promising easier access to ADHD treatment. Today, gaps in training, cost and access show why the reform was only a first st...
Read Full Article

Share this story

Report an error

Up next

Related Stories

How a plumber saved a plane from crashing

How a plumber saved a plane from crashing

Sydney Morning Herald

Why Melbourne is set for an intense hay fever, thunderstorm asthma season

Why Melbourne is set for an intense hay fever, thunderstorm asthma season

Sydney Morning Herald

Augustus locks onto multiple gold zones near Leonora in WA

Augustus locks onto multiple gold zones near Leonora in WA

Sydney Morning Herald

From tattoos to blue sausages, Newcastle has gone 'Knights crazy'

ABC News Australia

Labor MP accuses Greens leader of 'prejudice' over Jewish community comments

ABC News Australia

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!